Azitra, Inc. Stock Split Ratio
Azitra, Inc. (AZTR) had Stock Split Ratio of 15.02% as of 2025-08-21, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-08-12
- Azitra, Inc. stockholders' equity note, stock split, conversion ratio for the quarter ending 2024-03-31 was 710.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 3 month |
|---|---|---|
| 2025-08-21 | 15.02% 10-Q · filed 2026-08-12 | |
| 2024-07-01 | 3.33% 10-Q · filed 2026-08-12 | |
| 2024-03-31 | 710.00% 10-Q · filed 2024-05-09 | |
| 2023-05-17 | 710.00% 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |